肝性胸腔积液管理中的胸膜干预措施
肝性胸腔积液见于5%至15%的肝硬化伴门脉高压患者,常反映晚期肝病。由于高质量数据有限,本文以病例为基础讨论胸腔穿刺、置管引流、留置隧道式胸膜导管、胸膜固定术及手术干预的作用,并建议在多学科团队框架内管理,对不适合移植的难治性患者可考虑留置隧道式胸膜导管,对移植候选者常先系列胸腔穿刺。
要点
- 肝硬化伴门脉高压患者中肝性胸腔积液发生率为5%至15%。
- 难治性且非移植候选者建议留置隧道式胸膜导管,除非有禁忌。
- 管理应在呼吸科、肝病科和移植外科的多学科团队内进行。
核心结论
- 肝性胸腔积液的管理应基于现有数据与专家意见,在多学科团队框架内进行。
- 对不适合移植的难治性肝性胸腔积液患者,建议留置隧道式胸膜导管,除非有禁忌。
- 对肝病治疗方案不明确或不完整、或无法接受更 definitive 操作的患者,推荐系列胸腔穿刺。
- 对移植候选者,常将系列胸腔穿刺作为标准治疗,同时评估留置隧道式胸膜导管在病程和移植评估中的作用。
研究设计与样本
- 基于病例的综述,结合现有数据与专家意见讨论胸膜干预措施。
主要发现
- 肝性胸腔积液可表现为少量胸腔积液伴轻微肺部症状至大量胸腔积液伴呼吸衰竭。
- 患者常合并多种共病,管理困难且并发症风险高。
- 针对肝性胸腔积液的高质量数据有限,可能导致呼吸或重症监护医师在最佳管理选择上存在困难。
关键数值与推荐
- 肝性胸腔积液见于5%至15%的肝硬化伴门脉高压患者。
- 讨论的胸膜干预包括胸腔穿刺、胸腔置管引流、留置隧道式胸膜导管、胸膜固定术和手术干预。
临床怎么用
- 管理应在包括呼吸科、肝病科和移植外科的多学科团队内进行。
- 对难治性且非移植候选者,优先考虑留置隧道式胸膜导管(除非有禁忌)。
- 对肝病治疗方案不明确或不完整、或无法接受更 definitive 操作的患者,采用系列胸腔穿刺。
- 对移植候选者,常以系列胸腔穿刺为标准治疗,同时评估留置隧道式胸膜导管的作用。
局限性
- 针对肝性胸腔积液的高质量数据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hepatic hydrothorax can be present in 5% to 15% of patients with underlying cirrhosis and portal hypertension, often reflecting advanced liver disease. Its impact can be variable, because patients may have small pleural effusions and minimal pulmonary symptoms or massive pleural effusions and respiratory failure. Management of hepatic hydrothorax can be difficult because these patients often have a number of comorbidities and potential for complications. Minimal high-quality data are available for guidance specifically related to hepatic hydrothorax, potentially resulting in pulmonary or critical care physician struggling for best management options. We therefore provide a Case-based presentation with management options based on currently available data and opinion. We discuss the role of pleural interventions, including thoracentesis, tube thoracostomy, indwelling tunneled pleural catheter, pleurodesis, and surgical interventions. In general, we recommend that management be conducted within a multidisciplinary team including pulmonology, hepatology, and transplant surgery. Patients with refractory hepatic hydrothorax that are not transplant candidates should be managed with palliative intent; we suggest indwelling tunneled pleural catheter placement unless otherwise contraindicated. For patients with unclear or incomplete hepatology treatment plans or those unable to undergo more definitive procedures, we recommend serial thoracentesis. In patients who are transplant candidates, we often consider serial thoracentesis as a standard treatment, while also evaluating the role indwelling tunneled pleural catheter placement may play within the course of disease and transplant evaluation.
引用
- Gilbert CR, Shojaee S, Maldonado F, et al. Pleural Interventions in the Management of Hepatic Hydrothorax. Chest. 2021. PMID: 34390708. doi:10.1016/j.chest.2021.08.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。